Optimization of treatment of urolithiasis in patients with gout, complicated by nephropathy

Aim: to improve the treatment of urolithiasis in patients with gout, complicated nephropathy. 68 patients with urate urolithiasis and gout complicated nephropathy, including 24 women and 44 men aged from 42 to 88 years, mean age 61 ± 8.7 years were examined. Duration of illness ranged from 2 to 28 years, mean 11.7 ± 5.1 years. All patients were treated by Trometamol N 500 ml intravenously per day rated of 10 infusions and low intensive laser therapy. Conducted therapy results in the dissolution of concrements, the normalization of purine metabolism, improvement of renal function, manifested by increasinf of glomerular filtration and decreasing of blood creatinine. Conclusion. It is reasonable to use Trometamol N in the complex therapy of urolithiasis in patients with gout, complicated by nephropathy.

gout, uric acid, nephropathy, Trometamol N, urate concrements